Semler Scientific Reports Director/Officer Changes & Compensation
| Field | Detail |
|---|---|
| Company | Semler Scientific, Inc. |
| Form Type | 8-K |
| Filed Date | Oct 17, 2025 |
| Risk Level | medium |
| Pages | 7 |
| Reading Time | 9 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, compensation
Related Tickers: SMLR
TL;DR
Semler Scientific (SMLR) filed an 8-K detailing director/officer changes and compensation plans.
AI Summary
Semler Scientific, Inc. filed an 8-K on October 17, 2025, reporting events as of October 16, 2025. The filing indicates changes related to the departure of directors or certain officers, the election of directors, and the appointment of certain officers, as well as compensatory arrangements for certain officers. Specific details regarding these changes and arrangements are provided within the filing.
Why It Matters
Changes in a company's board of directors and executive officers, along with details on their compensation, can signal shifts in strategy, governance, or operational focus.
Risk Assessment
Risk Level: medium — Changes in key personnel and compensation can indicate internal shifts that may impact future performance or strategy.
Key Players & Entities
- Semler Scientific, Inc. (company) — Registrant
- October 16, 2025 (date) — Date of earliest event reported
- October 17, 2025 (date) — Filing date
FAQ
What specific roles have seen departures or appointments?
The filing indicates changes related to the departure of directors or certain officers, and the election/appointment of directors and officers, but does not specify the exact roles in this summary.
Are there any new directors or officers elected or appointed?
Yes, the filing explicitly mentions the election of directors and the appointment of certain officers.
What is the nature of the compensatory arrangements mentioned?
The filing states that there are compensatory arrangements for certain officers, but the specific details of these arrangements are not provided in the summary.
When were these events reported to have occurred?
The earliest event reported occurred on October 16, 2025.
What is the company's principal executive office address?
The company's principal executive offices are located at 51 E Campbell Ave, Suite 107-D, Campbell, CA 95008.
Filing Stats: 2,196 words · 9 min read · ~7 pages · Grade level 17.6 · Accepted 2025-10-17 16:10:11
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value per share SMLR The Nasdaq
Filing Documents
- smlr-20251016x8k.htm (8-K) — 57KB
- 0001554859-25-000057.txt ( ) — 171KB
- smlr-20251016.xsd (EX-101.SCH) — 3KB
- smlr-20251016_lab.xml (EX-101.LAB) — 16KB
- smlr-20251016_pre.xml (EX-101.PRE) — 10KB
- smlr-20251016x8k_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SEMLER SCIENTIFIC, INC. Date: October 17, 2025 By: /s/ Douglas Murphy-Chutorian Name: Douglas Murphy-Chutorian, M.D. Title: President and Chief Executive Officer (Principal Executive Officer)